tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Annovis Bio’s Promising Alzheimer’s Drug Trial: What Investors Need to Know
PremiumCompany AnnouncementsAnnovis Bio’s Promising Alzheimer’s Drug Trial: What Investors Need to Know
2M ago
Annovis Bio’s Strategic Advancements and Phase 3 Study Progress Support Buy Rating
Premium
Ratings
Annovis Bio’s Strategic Advancements and Phase 3 Study Progress Support Buy Rating
2M ago
Annovis Bio completes full patent transfer to crystal buntanetap
Premium
The Fly
Annovis Bio completes full patent transfer to crystal buntanetap
2M ago
Annovis Bio rises 16.3%
PremiumThe FlyAnnovis Bio rises 16.3%
3M ago
Annovis Bio Approves Board Elections and Auditor Appointment
Premium
Company Announcements
Annovis Bio Approves Board Elections and Auditor Appointment
3M ago
Annovis Bio’s NYSE Compliance Plan Accepted
Premium
Company Announcements
Annovis Bio’s NYSE Compliance Plan Accepted
3M ago
Annovis Bio price target lowered to $17 from $26 at Canaccord
PremiumThe FlyAnnovis Bio price target lowered to $17 from $26 at Canaccord
5M ago
Annovis Bio Appoints New Principal Financial Officer
Premium
Company Announcements
Annovis Bio Appoints New Principal Financial Officer
5M ago
Annovis Bio appoints Liu as Director of Biostatistics
Premium
The Fly
Annovis Bio appoints Liu as Director of Biostatistics
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100